These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21125076)

  • 21. Evaluating an implementation strategy in cardiovascular prevention to improve prescribing of statins in Germany: an intention to treat analysis.
    Keller H; Hirsch O; Kaufmann-Kolle P; Krones T; Becker A; Sönnichsen AC; Baum E; Donner-Banzhoff N
    BMC Public Health; 2013 Jul; 13():623. PubMed ID: 23819600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.
    Persell SD; Brown T; Lee JY; Shah S; Henley E; Long T; Luther S; Lloyd-Jones DM; Jean-Jacques M; Kandula NR; Sanchez T; Baker DW
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):560-6. PubMed ID: 26555123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins for all: should patients who have migraine with aura be on a statin?
    Kernick D
    Br J Gen Pract; 2015 Nov; 65(640):571-2. PubMed ID: 26500300
    [No Abstract]   [Full Text] [Related]  

  • 24. eComment: Statins and ACE-inhibitors.
    Hudorovic N
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):581. PubMed ID: 18664661
    [No Abstract]   [Full Text] [Related]  

  • 25. Managing cardiovascular risk factors: the gap between evidence and practice.
    Turnbull F
    PLoS Med; 2005 May; 2(5):e131. PubMed ID: 15916459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins in the elderly: what evidence of their benefit in prevention?
    Steg PG; Tissot CM
    Arch Cardiovasc Dis; 2010 Feb; 103(2):61-5. PubMed ID: 20226424
    [No Abstract]   [Full Text] [Related]  

  • 27. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
    Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population health impact of statin treatment in Canada.
    Hennessy DA; Tanuseputro P; Tuna M; Bennett C; Perez R; Shields M; Ko DT; Tu J; Manuel DG
    Health Rep; 2016 Jan; 27(1):20-8. PubMed ID: 26788719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New analysis fuels debate on merits of prescribing statins to low risk people.
    Kmietowicz Z
    BMJ; 2014 Mar; 348():g2370. PubMed ID: 24671956
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence-based prescribing: combining network meta-analysis with multicriteria decision analysis to choose among multiple drugs.
    Naci H; van Valkenhoef G; Higgins JP; Fleurence R; Ades AE
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):787-92. PubMed ID: 25097214
    [No Abstract]   [Full Text] [Related]  

  • 31. Cholesterol drug lowers LDL-C levels but again fails to show clinical benefit.
    Mitka M
    JAMA; 2010 Jan; 303(3):211-2. PubMed ID: 20085945
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment with statins].
    Bogsrud MP; Reikvam Å; Retterstøl K
    Tidsskr Nor Laegeforen; 2013 Jun; 133(12-13):1316-9. PubMed ID: 23817262
    [No Abstract]   [Full Text] [Related]  

  • 33. Most statins prescribed in the UK go to the wrong patients, study finds.
    Kmietowicz Z
    BMJ; 2013 Aug; 347():f5048. PubMed ID: 23940293
    [No Abstract]   [Full Text] [Related]  

  • 34. Statin Prescribing Practices in the Comprehensive Care for HIV-Infected Patients.
    Kelly SG; Krueger KM; Grant JL; Penugonda S; Feinstein MJ; Taiwo BO; Achenbach CJ
    J Acquir Immune Defic Syndr; 2017 Sep; 76(1):e26-e29. PubMed ID: 28520617
    [No Abstract]   [Full Text] [Related]  

  • 35. Updated Recommendations for Preventing CVD with Statins.
    Zolot J
    Am J Nurs; 2017 Feb; 117(2):15. PubMed ID: 28125479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins: new US guideline sparks controversy.
    Lancet; 2013 Nov; 382(9906):1680. PubMed ID: 24267985
    [No Abstract]   [Full Text] [Related]  

  • 37. Evolving Approaches for Statins in Primary Prevention: Progress, but Questions Remain.
    Navar AM; Peterson ED
    JAMA; 2016 Nov; 316(19):1981-1983. PubMed ID: 27838704
    [No Abstract]   [Full Text] [Related]  

  • 38. Statins: new American guidelines for prevention of cardiovascular disease.
    Ridker PM; Cook NR
    Lancet; 2013 Nov; 382(9907):1762-5. PubMed ID: 24268611
    [No Abstract]   [Full Text] [Related]  

  • 39. More than a billion people taking statins?: Potential implications of the new cardiovascular guidelines.
    Ioannidis JP
    JAMA; 2014 Feb; 311(5):463-4. PubMed ID: 24296612
    [No Abstract]   [Full Text] [Related]  

  • 40. Audit-based education to reduce suboptimal management of cholesterol in primary care: a before and after study.
    de Lusignan S; Belsey J; Hague N; Dhoul N; van Vlymen J
    J Public Health (Oxf); 2006 Dec; 28(4):361-9. PubMed ID: 17038329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.